The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan

OBJECTIVE: Hyponatremia is frequently observed in patients with decompensated liver cirrhosis and it is also related to a poor prognosis. The vasopressin V2-receptor antagonist tolvaptan is used to treat cirrhotic patients with ascites and increases the serum sodium (Na) level. In this study, we inv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Principais autores: Kogiso, Tomomi, Kobayashi, Mutsuki, Yamamoto, Kuniko, Ikarashi, Yuichi, Kodama, Kazuhisa, Taniai, Makiko, Torii, Nobuyuki, Hashimoto, Etsuko, Tokushige, Katsutoshi
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725852/
https://ncbi.nlm.nih.gov/pubmed/28943585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.9033-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados